Balance Labs, Inc.
BLNC
$1.55
-$0.02-1.27%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.00K | -- | -- | -- | -- |
| Cost of Revenue | 12.61M | 182.80K | 46.70K | 49.50K | 47.30K |
| Gross Profit | -12.61M | -182.80K | -46.70K | -49.50K | -47.30K |
| SG&A Expenses | 127.70K | 28.30K | 32.50K | 29.30K | 16.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.74M | 211.10K | 79.30K | 78.80K | 64.00K |
| Operating Income | -12.74M | -211.10K | -79.30K | -78.80K | -64.00K |
| Income Before Tax | -28.02M | -3.59M | -146.10K | -6.40K | -117.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.02M | -3.59M | -146.10K | -6.40K | -117.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.02M | -3.59M | -146.10K | -6.40K | -117.70K |
| EBIT | -12.74M | -211.10K | -79.30K | -78.80K | -64.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.75 | -0.16 | -0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | -0.19 | -0.10 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.75 | -0.16 | -0.01 | 0.00 | -0.01 |
| Normalized Diluted EPS | -0.19 | -0.10 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 37.54M | 22.00M | 21.67M | 21.67M | 21.67M |
| Average Diluted Shares Outstanding | 37.54M | 22.00M | 21.67M | 21.67M | 21.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |